Improving Quality and Safety In Your Endoscopy Unit: On-Demand | October 2022 OLQUALOCT22-Guideline

Guideline_ASGE antithrombotics

Pdf Summary

This document provides guidelines for the management of antithrombotic agents during gastrointestinal endoscopy. It emphasizes the need for individualized decision-making based on factors such as the urgency of the procedure, bleeding risk, and risk of thromboembolic events. The guidelines outline bleeding risks for different endoscopic procedures and recommend appropriate cessation and reinitiation of antithrombotic therapy. Collaboration between endoscopists and prescribing physicians is crucial, and bridge therapy may be considered for elective procedures. The document also discusses the safety of endoscopic evaluation and therapy in patients on antithrombotics with active GI bleeding, as well as recommendations for specific anticoagulants and antiplatelet agents. Further research is needed for managing newer antithrombotic agents and specific endoscopic techniques.

Keywords

antithrombotic agents

gastrointestinal endoscopy

individualized decision-making

bleeding risk

thromboembolic events

endoscopic procedures

collaboration

bridge therapy

elective procedures

therapy safety